NBY  Novabay Pharmaceuticals Inc.

Exchange

AMEX

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

54.48M

Vuru Grade

31.66/100

Current Price

$3.60
-0.05 (-1.37%)

Company Metrics

  • P/E 0
  • P/S 5.84
  • P/B 8.08
  • EPS -2.44
  • Cash ROIC 921.20%
  • Cash Ratio 0.51
  • Dividend 0 / 0%
  • Avg. Vol. 25,836.00
  • Shares 2.78M
  • Market Cap. 54.48M

Company Description

NovaBay Pharmaceuticals Inc., a clinical stage biotechnology company, engages in developing proprietary and patented topical Aganocide compounds for the treatment and prevention of various infections without causing bacterial resistance. Its Aganocide compounds are synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white bloo... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

NovaBay Pharma's (NBY) Hold Rating Reaffirmed at Maxim Group
Sports Perspectives - 10 hours ago
Maxim Group reaffirmed their hold rating on shares of NovaBay Pharma (NYSE:NBY) in a report published on Thursday. NovaBay Pharma (NYSE:NBY) traded down 1.37% on Thursday, reaching $3.60. The company's stock had a trading volume of 207 ...
Next Weeks Broker Price Targets For NovaBay Pharmaceuticals, Inc. (NBY) - Fiscal Standard
News NovaBay Pharmaceuticals Inc.NBY
Wall Street Journal - Feb 11, 2011
News NovaBay Pharmaceuticals Inc.NBY. Significant News Only. 12/01/16; Press Release. NovaBay to Present at LD Micro Main Event.
NovaBay Pharmaceuticals Announces Preliminary Sales for the Fourth Quarter of 2016
Yahoo Finance - Jan 9, 2017
NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® lid and lash hygiene for the domestic eye care market, announces that Avenova sales for the fourth quarter of 2016 are ...
Williams %R Check on Shares of NovaBay Pharmaceuticals Inc. (NBY)
Yankee Analysts - Jan 19, 2017
Dedicated investors tracking NovaBay Pharmaceuticals Inc. (NBY) shares may be looking to employ technical stock analysis tools.
Where Does NovaBay Pharmaceuticals, Inc. (NYSEMKT: NBY) Have Its Focus This Year?
Scibility Media - Aug 15, 2016
NovaBay Pharmaceuticals, Inc. (NYSEMKT: NBY) has set for itself many targets to hit before the end of 2016. But there is one that the management of the company has been talking about repeatedly: achieving positive cash flow.
NovaBay Pharmaceuticals Announces Restructuring to Focus on Avenova ...
Business Wire (press release) - Nov 19, 2015
BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY) announces a corporate restructuring to focus on the commercialization of its prescription Avenova® Lid and Lash Cleanser. NovaBay is also taking steps to reduce operating expenses ...
NovaBay Pharmaceuticals Reports 2016 Second Quarter Financial Results
Business Wire (press release) - Aug 11, 2016
BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova lid and lash hygiene product for the domestic eye care market, reports financial results for the three ...
NovaBay Pharmaceuticals Signs Distribution Agreement to Make Avenova Available ...
Business Wire (press release) - Sep 2, 2015
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today announced that the ...
NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results
Business Wire (press release) - Nov 10, 2016
BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, reports financial results for the three ...
NovaBay Pharmaceuticals Announces $2.83 Million Private Placement
Business Wire (press release) - Feb 24, 2016
BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY) a biopharmaceutical company focusing on commercializing its Avenova® Lid and Lash Cleanser for the domestic eye care market, announces that it has entered into three securities ...